Vascular Invasion Predicts Recurrence in Stage IA2-IB Lung Adenocarcinoma but not Squamous Cell Carcinoma

CONCLUSION: Vascular invasion is a strong predictor of recurrence in stage IA2-IB LUAD but not in LUSC. Adjuvant therapy trials should be directed at this subgroup.PMID:36631388 | DOI:10.1016/j.cllc.2022.12.006
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research